Related Experiment Video
Updated: Jan 27, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease
Moises Rodriguez-Gonzalez1, Alvaro A Perez-Reviriego2, Ana Castellano-Martinez3
1Department of Pediatric Cardiology, Puerta del Mar University Hospital, Cadiz 11011 Spain.
Insights
Early recognition of Kawasaki disease (KD) is crucial. N-terminal probrain natriuretic peptide shows promise as a biomarker to improve the diagnosis of this childhood vasculitis, aiding timely treatment.
Area of Science:
- Pediatrics
- Cardiology
- Immunology
Background:
- Kawasaki disease (KD) is a critical childhood vasculitis affecting the heart.
- Coronary artery aneurysms are a major cause of mortality in KD patients.
- Early diagnosis and treatment with gammaglobulin reduce aneurysm risk.
Purpose of the Study:
- To review the diagnostic utility of N-terminal probrain natriuretic peptide (NT-proBNP) in Kawasaki disease.
- To assess NT-proBNP as a biomarker for enhancing KD diagnosis.
Main Methods:
- Literature review of recent studies on NT-proBNP in KD diagnosis.
- Analysis of diagnostic accuracy of NT-proBNP in suspected KD cases.
Main Results:
- NT-proBNP demonstrates significant potential as a biomarker for KD.
- Incorporating NT-proBNP can improve the accuracy of current diagnostic methods for KD.
Conclusions:
- NT-proBNP is a valuable addition to the diagnostic workup for suspected Kawasaki disease.
- This biomarker can increase diagnostic accuracy, facilitating earlier intervention for KD.
Abstract:
Kawasaki disease (KD) is a systemic childhood vasculitis with peculiar tropism for the heart. Coronary artery aneurysms are the primary cause of morbidity and mortality in these patients. The timely administration of gammaglobulin decreases the risk for development of coronary artery aneurysms, highlighting the importance of early KD recognition. However, the most significant dilemma in the management of KD is the diagnosis itself. In this article, we review the recent literature focusing on the diagnostic utility of N-terminal probrain natriuretic peptide as a biomarker for diagnosis of KD. The main conclusion is that N-terminal probrain natriuretic peptide is an useful biomarker for KD diagnostic that represents a valuable addition to the current diagnostic workup of patients with suspected KD, increasing the diagnostic accuracy.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Peptide Bonds
Termination of Translation
Termination of Translation
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Documentation of Nursing Diagnosis
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters...

